Literature DB >> 27457067

Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation.

N Krezdorn1,2, N Murakami3, B Pomahac1, L V Riella4.   

Abstract

Entities:  

Keywords:  T cell biology; clinical research/practice; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: belatacept; immunobiology; immunosuppressant; immunosuppression/immune modulation; immunosuppressive regimens; maintenance; rejection: acute; side effects; vascularized composite and reconstructive transplantation

Mesh：

Substances：

Year:  2016        PMID： 27457067      PMCID： PMC5087655          DOI： 10.1111/ajt.13977

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  5 in total

1.  Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.

Authors:  E J Kim; J Kwun; A C Gibby; J J Hong; A B Farris; N N Iwakoshi; F Villinger; A D Kirk; S J Knechtle
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

2.  Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.

Authors:  Josh Levitsky; Joshua Miller; Xuemei Huang; Dhivya Chandrasekaran; Li Chen; James M Mathew
Journal:  Transplantation       Date:  2013-10-27       Impact factor: 4.939

3.  Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.

Authors:  T J Borges; J T O'Malley; L Wo; N Murakami; B Smith; J Azzi; S Tripathi; J D Lane; E M Bueno; R A Clark; S G Tullius; A Chandraker; C G Lian; G F Murphy; T B Strom; B Pomahac; N Najafian; L V Riella
Journal:  Am J Transplant       Date:  2016-04-07       Impact factor: 8.086

4.  High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.

Authors:  S M Krummey; J A Cheeseman; J A Conger; P S Jang; A K Mehta; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2014-03       Impact factor: 8.086

5.  CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection.

Authors:  J Espinosa; F Herr; G Tharp; S Bosinger; M Song; A B Farris; R George; J Cheeseman; L Stempora; R Townsend; A Durrbach; A D Kirk
Journal:  Am J Transplant       Date:  2016-01-14       Impact factor: 8.086
  5 in total
  5 in total

1.  The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation.

Authors:  Valentin Haug; Branislav Kollar; Doha Obed; Harriet Kiwanuka; Marvee Turk; Luccie Wo; Sotirios Tasigiorgos; Maximillian Kueckelhaus; Leonardo V Riella; Bohdan Pomahac
Journal:  JAMA Facial Plast Surg       Date:  2019-07-01       Impact factor: 4.611

2.  Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.

Authors:  Thet Su Win; William J Crisler; Beatrice Dyring-Andersen; Rachel Lopdrup; Jessica E Teague; Qian Zhan; Victor Barrera; Shannan Ho Sui; Sotirios Tasigiorgos; Naoka Murakami; Anil Chandraker; Stefan G Tullius; Bohdan Pomahac; Leonardo V Riella; Rachael A Clark
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

3.  MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study.

Authors:  Branislav Kollar; Audrey Uffing; Thiago J Borges; Andrey V Shubin; Bruno T Aoyama; Céline Dagot; Valentin Haug; Martin Kauke; Ali-Farid Safi; Simon G Talbot; Emmanuel Morelon; Stéphanie Dakpe; Bohdan Pomahac; Leonardo V Riella
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

Review 4.  Costimulation Blockade in Vascularized Composite Allotransplantation.

Authors:  Dimitrios Giannis; Dimitrios Moris; Linda C Cendales
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

5.  Kidney Dysfunction After Vascularized Composite Allotransplantation.

Authors:  Nicco Krezdorn; Sotirios Tasigiorgos; Luccie Wo; Rachel Lopdrup; Marvee Turk; Harriet Kiwanuka; Salman Ahmed; Palmina Petruzzo; Ericka Bueno; Bohdan Pomahac; Leonardo V Riella
Journal:  Transplant Direct       Date:  2018-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.